BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liang T, Zhang Y, Wu S, Chen Q, Wang L. The Role of NLRP3 Inflammasome in Alzheimer’s Disease and Potential Therapeutic Targets. Front Pharmacol 2022;13:845185. [DOI: 10.3389/fphar.2022.845185] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Rudnicka-drożak E, Drożak P, Mizerski G, Zaborowski T, Ślusarska B, Nowicki G, Drożak M. Links between COVID-19 and Alzheimer’s Disease—What Do We Already Know? IJERPH 2023;20:2146. [DOI: 10.3390/ijerph20032146] [Reference Citation Analysis]
2 Ishabiyi FO, Ogidi J, Olukade BA, Amorha CC, El-Sharkawy LY, Okolo CC, Adeniyi TM, Atasie NH, Ibrahim A, Balogun TA. Computational Evaluation of Azadirachta indica-Derived Bioactive Compounds as Potential Inhibitors of NLRP3 in the Treatment of Alzheimer's Disease. J Alzheimers Dis 2023. [PMID: 36683510 DOI: 10.3233/JAD-221020] [Reference Citation Analysis]
3 Yang Z, Liu J, Wei S, Deng J, Feng X, Liu S, Liu M. A novel strategy for bioactive natural products targeting NLRP3 inflammasome in Alzheimer's disease. Front Pharmacol 2022;13:1077222. [PMID: 36699095 DOI: 10.3389/fphar.2022.1077222] [Reference Citation Analysis]
4 Vontell RT, de Rivero Vaccari JP, Sun X, Gultekin SH, Bramlett HM, Dietrich WD, Keane RW. Identification of inflammasome signaling proteins in neurons and microglia in early and intermediate stages of Alzheimer's disease. Brain Pathol 2022;:e13142. [PMID: 36579934 DOI: 10.1111/bpa.13142] [Reference Citation Analysis]
5 Xu W, Ren B, Zhang Z, Chen C, Xu T, Liu S, Ma C, Wang X, Wang Q, Cheng F. Network pharmacology analysis reveals neuroprotective effects of the Qin-Zhi-Zhu-Dan Formula in Alzheimer’s disease. Front Neurosci 2022;16:943400. [DOI: 10.3389/fnins.2022.943400] [Reference Citation Analysis]
6 Sæther LS, Ueland T, Haatveit B, Maglanoc LA, Szabo A, Djurovic S, Aukrust P, Roelfs D, Mohn C, Greenwood Ormerod MBE, Lagerberg TV, Steen NE, Melle I, Andreassen OA, Ueland T. Inflammation and cognition in severe mental illness: Patterns of covariation and subgroups.. [DOI: 10.1101/2022.08.25.22279209] [Reference Citation Analysis]
7 Zhang L, Song H, Ding J, Wang DJ, Zhu SP, Liu C, Jin X, Chen JW. The Mechanism of TNF-α-Mediated Accumulation of Phosphorylated Tau Protein and Its Modulation by Propofol in Primary Mouse Hippocampal Neurons: Role of Mitophagy, NLRP3, and p62/Keap1/Nrf2 Pathway. Oxid Med Cell Longev 2022;2022:8661200. [PMID: 35993019 DOI: 10.1155/2022/8661200] [Reference Citation Analysis]
8 Jose S, Groves NJ, Roper KE, Gordon R. Mechanisms of NLRP3 activation and pathology during neurodegeneration. Int J Biochem Cell Biol 2022;:106273. [PMID: 35926782 DOI: 10.1016/j.biocel.2022.106273] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Nguyen HD, Jo WH, Hoang NHM, Kim MS. Curcumin-Attenuated TREM-1/DAP12/NLRP3/Caspase-1/IL1B, TLR4/NF-κB Pathways, and Tau Hyperphosphorylation Induced by 1,2-Diacetyl Benzene: An in Vitro and in Silico Study. Neurotox Res 2022. [PMID: 35781221 DOI: 10.1007/s12640-022-00535-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zhang H, Li N, Li Z, Li Y, Yu Y, Zhang L. The Involvement of Caspases in Neuroinflammation and Neuronal Apoptosis in Chronic Pain and Potential Therapeutic Targets. Front Pharmacol 2022;13:898574. [PMID: 35592413 DOI: 10.3389/fphar.2022.898574] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]